Evidence map›Paper›PMID 23572525›Full record

ArticleThe Journal of biological chemistry2013

Plekhg4 is a novel Dbl family guanine nucleotide exchange factor protein for rho family GTPases.

Meghana Gupta, Elena Kamynina, Samantha Morley, Stacey Chung, Nora Muakkassa, Hong Wang, Shayna Brathwaite, Gaurav Sharma, Danny Manor

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Benzene metabolites increase vascular permeability by activating heat shock proteins and Rho GTPases.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  3. Article
  4. Review
  5. Roles of the Dbl family of RhoGEFs in mechanotransduction - a review.Frontiers in cell and developmental biology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Meghana GuptaDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
Elena KamyninaCornell University, Ithaca, New York 14853.
Samantha MorleyDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
Stacey ChungDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
Nora MuakkassaCornell University, Ithaca, New York 14853.
Hong WangDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
Shayna BrathwaiteDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
Gaurav SharmaCornell University, Ithaca, New York 14853.
Danny ManorDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106; Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106. Electronic address: dxm178@case.edu.
Case Western Reserve University · USCornell University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
ONOCOLOGY TRAINING GRANTT32CA009338 · NCI · OHIO STATE UNIVERSITY · PI BYRD, JOHN C., POLLOCK, RAPHAEL E. · 1985 to 2018
$8.3M
Cell Transformation by Dbl-like onco-proteinsR01CA082391 · NCI · CORNELL UNIVERSITY ITHACA · PI MANOR, DANNY · 2002 to 2006
$1.3M
CELL TRANSFORMATION BY DBL LIKE ONCOPROTEINSR55CA082391 · NCI · CORNELL UNIVERSITY ITHACA · PI MANOR, DANNY · 1999 to 1999
–
NCI NIH HHS 5P30-CA043703NCI NIH HHS CA82391NCI NIH HHS P30 CA043703NCI NIH HHS R01 CA082391NCI NIH HHS R55 CA082391NCI NIH HHS T32 CA009338
6 · The paper itself

Abstract

Mutations in the PLEKHG4 (puratrophin-1) gene are associated with the heritable neurological disorder autosomal dominant spinocerebellar ataxia. However, the biochemical functions of this gene product have not been described. We report here that expression of Plekhg4 in the murine brain is developmentally regulated, with pronounced expression in the newborn midbrain and brainstem that wanes with age and maximal expression in the cerebellar Purkinje neurons in adulthood. We show that Plekhg4 is subject to ubiquitination and proteasomal degradation, and its steady-state expression levels are regulated by the chaperones Hsc70 and Hsp90 and by the ubiquitin ligase CHIP. On the functional level, we demonstrate that Plekhg4 functions as a bona fide guanine nucleotide exchange factor (GEF) that facilitates activation of the small GTPases Rac1, Cdc42, and RhoA. Overexpression of Plekhg4 in NIH3T3 cells induces rearrangements of the actin cytoskeleton, specifically enhanced formation of lamellopodia and fillopodia. These findings indicate that Plekhg4 is an aggregation-prone member of the Dbl family GEFs and that regulation of GTPase signaling is critical for proper cerebellar function.

Indexed as

Gene Expression Regulation, EnzymologicActinsAmino Acid SequenceAnimalsBrainChlorocebus aethiopsCOS CellsCytoskeletonDisease Models, AnimalEscherichia coliGuanine Nucleotide Exchange FactorsMiceMolecular Sequence DataMutationNIH 3T3 CellsPseudopodiaActinsGuanine Nucleotide Exchange FactorsMcf2 protein, mousePLEKHG4 protein, mouserho GTP-Binding ProteinsUbiquitinAggregationAtaxiaCerebellumGTPaseGuanine Nucleotide Exchange Factor (GEF)Heat Shock ProteinUbiquitination

Identifiers

PMID23572525
PMCPMC3656306
OpenAlexW1999561836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.